BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HECN30227 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HECN30227\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07771140-11021@assetmemo.bio
DTSTAMP:20261121T005637Z
DTSTART;VALUE=DATE:20270411
DTEND;VALUE=DATE:20270412
SUMMARY:HECN30227: Phase 1 readout est. (NCT07771140)
DESCRIPTION:HECN30227\, phase 1\, Chronic Hepatitis B.\nStudy: A Phase I Cl
 inical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subje
 cts With Chronic Hepatitis B\nEstimated primary completion: 11 April 2027.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/hecn30227#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07771140
URL:https://assetmemo.bio/drug/hecn30227#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
